Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Large Cell × vandetanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Medullary 4 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Familial medullary thyroid carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

figitumumab 2 vandetanib 1 cemiplimab 1 brigatinib 1 alpha-2'-deoxythioguanosine 1 Vinorelbine 1 Paclitaxel 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Docetaxel 1 Crizotinib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00404924 2016-09-30

ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures

Sanofi

Phase 3 Completed

1,140 enrolled 12 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡